Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|April 20, 2026
Reimagining Carrier-Based Formulations for Inhalation: Respirable AgglomeratesJeffry G Weers, Thomas E Tarara, Danforth P MillerAAPS Pharmscitech|February 9, 2019
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug ParticlesJeffry G Weers, Danforth P Miller, Thomas E TararaJournal of Aerosol Medicine and Pulmonary Drug Delivery|June 8, 2026
Design of Dry Powder Inhalers: 2. The Impact of Suboptimal Peak Inspiratory Flow Rates on Bronchodilation in Patients with Obstructive Lung DiseasesJeffry G Weers, Thomas E Tarara, Danforth P MillerPharmaceutics|November 27, 2021
Targeting of Inhaled Therapeutics to the Small Airways: Nanoleucine Carrier FormulationsDanforth P Miller, Thomas E Tarara, Jeffry G WeersJournal of Aerosol Medicine and Pulmonary Drug Delivery|June 8, 2026
Design of Dry Powder Inhalers: 1. Does Size Matter?Jeffry G Weers, Thomas E Tarara, Danforth P MillerMolecular Pharmaceutics|June 9, 2015
Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the LungsDanforth P Miller, Trixie Tan, Thomas E Tarara, et al.Molecular Pharmaceutics|April 19, 2017
Physical Characterization of Tobramycin Inhalation Powder: II. State Diagram of an Amorphous Engineered Particle FormulationDanforth P Miller, Trixie Tan, John Nakamura, et al.Journal of Pharmaceutical Sciences|August 22, 2015
Formulation Design of Dry Powders for InhalationJeffry G Weers, Danforth P MillerPharmaceutical Research|July 14, 2026
Spray-Dried Formulations of Relaxin-H2 for InhalationDanforth P Miller, Nani P Kadrichu, Thomas E Tarara, et al.Biorxiv : the Preprint Server for Biology|July 16, 2025
Molecular prosthetics and CFTR modulators additively increase secretory HCO<sub>3</sub> <sup>-</sup> flux in cystic fibrosis airway epitheliaNohemy Celis, Danforth P Miller, Thomas E Tarara, et al.Pageof 4